MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 249 filers reported holding MIRATI THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,319,000 | +15.4% | 104,800 | +10.9% | 3.15% | -10.8% |
| Q2 2022 | $6,344,000 | +47.0% | 94,500 | +80.0% | 3.53% | +75.2% |
| Q1 2022 | $4,317,000 | +47.1% | 52,500 | +162.5% | 2.02% | +63.6% |
| Q4 2021 | $2,934,000 | +90.3% | 20,000 | +122.2% | 1.23% | +121.8% |
| Q1 2021 | $1,542,000 | +16.5% | 9,000 | -47.1% | 0.56% | -41.8% |
| Q3 2019 | $1,324,000 | -79.4% | 17,000 | -72.8% | 0.96% | -58.2% |
| Q2 2019 | $6,438,000 | +114.2% | 62,500 | +52.4% | 2.29% | +60.2% |
| Q1 2019 | $3,005,000 | -2.1% | 41,000 | -59.0% | 1.43% | +185.2% |
| Q1 2018 | $3,070,000 | +8.5% | 100,000 | -35.5% | 0.50% | -6.2% |
| Q4 2017 | $2,829,000 | +242.5% | 155,000 | +24.0% | 0.53% | +72.3% |
| Q3 2016 | $826,000 | +20.9% | 125,000 | 0.0% | 0.31% | -5.5% |
| Q2 2016 | $683,000 | -69.1% | 125,000 | +21.0% | 0.33% | -73.5% |
| Q1 2016 | $2,210,000 | -20.9% | 103,283 | +16.8% | 1.24% | -7.6% |
| Q4 2015 | $2,795,000 | – | 88,439 | – | 1.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |